Jason Coloma
Vermögen: 29 Mio $ am 30.09.2026
Vermögen: 29 Mio $ am 30.09.2026
Jason V.
Coloma is currently President, Chief Executive Officer & Director at Maze Therapeutics, Inc. since 2019.
Dr. Coloma is also Director at St. Anthony's Foundation and Director at Braveheart Bio, Inc. starting in 2024.
Former roles include Independent Director at BioAge Labs, Inc. from 2021 to 2024; Chief Business Officer & Senior Vice President at Corvus Pharmaceuticals, Inc. from 2016 to 2017; Vice President & Global Head-Oncology Partnering at Roche Diagnostics Corp.
from 2007 to 2016; Chief Business Officer at Insitro, Inc. from 2018 to 2019; and Chief Business Officer at Celsius Therapeutics, Inc. from 2017 to 2018.
Education includes graduate and doctorate degrees from the University of California, Berkeley; an undergraduate degree from the University of San Francisco; and an MBA from the Tuck School of Business at Dartmouth.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
1,22 % | 06.08.2026 | 1.100.456 ( 1,22 % ) | 22 Mio $ | 30.09.2026 |
Maze Therapeutics, Inc.
Maze Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicine for cardiovascular, renal and metabolic diseases 0,42 % | 01.10.2026 | 234.367 ( 0,42 % ) | 6 Mio $ | 30.09.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
Maze Therapeutics, Inc.
Maze Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicine for cardiovascular, renal and metabolic diseases | Vorstandsvorsitzender | 01.06.2019 |
St. Anthony's Foundation
St. Anthony's Foundation Miscellaneous Commercial ServicesCommercial Services Operates as a social service organization which works to feed, cloth, heal and lift the spirits of people | Direktor/Vorstandsmitglied | - |
| Unternehmen | Position | Ende |
|---|---|---|
| BIOAGE LABS, INC. | Direktor/Vorstandsmitglied | 20.08.2024 |
Insitro, Inc.
Insitro, Inc. BiotechnologyHealth Technology Operates as a biology based AI therapeutics company | Corporate Officer/Principal | 01.08.2019 |
Celsius Therapeutics, Inc.
Celsius Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops therapeutics and medicines for inflammatory diseases | Corporate Officer/Principal | 01.11.2018 |
| CORVUS PHARMACEUTICALS, INC. | Investor Relations Kontakt | 01.07.2017 |
Roche Diagnostics Corp.
Roche Diagnostics Corp. Medical SpecialtiesHealth Technology Develops and produces medical tests and digital tools | Corporate Officer/Principal | 01.07.2016 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 10 |
|---|---|
Corvus Pharmaceuticals, Inc.
Corvus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides anticancer immuno-oncology drugs | Health Technology |
Roche Diagnostics Corp.
Roche Diagnostics Corp. Medical SpecialtiesHealth Technology Develops and produces medical tests and digital tools | Health Technology |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of San Francisco
University of San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
St. Anthony's Foundation
St. Anthony's Foundation Miscellaneous Commercial ServicesCommercial Services Operates as a social service organization which works to feed, cloth, heal and lift the spirits of people | Commercial Services |
Tuck School of Business at Dartmouth
Tuck School of Business at Dartmouth Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioAge Labs, Inc.
BioAge Labs, Inc. BiotechnologyHealth Technology Develops therapies obesity for metabolic diseases | Health Technology |
Insitro, Inc.
Insitro, Inc. BiotechnologyHealth Technology Operates as a biology based AI therapeutics company | Health Technology |
Celsius Therapeutics, Inc.
Celsius Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops therapeutics and medicines for inflammatory diseases | Health Technology |
Maze Therapeutics, Inc.
Maze Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicine for cardiovascular, renal and metabolic diseases | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen